Can We “Hedge” against the Development of Antiviral Resistance among Pandemic Influenza Viruses?

David K Shay and Benjamin J Ridenhour

PLOS Medicine, 2009, vol. 6, issue 6, 1-2

Abstract: David K. Shay and Benjamin Ridenhour discuss a modeling study predicting that stockpiling a secondary antiviral for use early in a flu pandemic can forestall resistance to the primary stockpiled drug.

Date: 2009
References: Add references at CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1000103 (text/html)
https://journals.plos.org/plosmedicine/article/fil ... 00103&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pmed00:1000103

DOI: 10.1371/journal.pmed.1000103

Access Statistics for this article

More articles in PLOS Medicine from Public Library of Science
Bibliographic data for series maintained by plosmedicine ().